← Back to graph
Supplement

CoQ10 ubiquinone sublingual

Selected indexed studies

  • Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial. (Cardiovasc Diabetol, 2024) [PMID:38987784]
  • Effect of coenzyme Q10 supplementation on oxidative stress and clinical outcomes in patients with low levels of coenzyme Q10 admitted to the intensive care unit. (J Nutr Sci, 2021) [PMID:34290862]
  • Assessment of the effectiveness of a sublingual, ergogenic spray on muscle strength and power. (J Strength Cond Res, 2009) [PMID:19826292]

_Worker-drafted node — pending editorial review._

Connections

CoQ10 ubiquinone sublingual protects against

CoQ10 ubiquinone sublingual helps

Sources

Local graph